Lemonaid Health vs Layla

Lemonaid publishes a useful cash-pay menu, but its $49 membership must be added to every medication price.

Layla's official pages contain material price conflicts, so no current starting rate is safe to publish.

Clinician review is required and the site distinguishes compounded products from FDA-approved brands.

Independent clinicians review treatment, while product and pharmacy details require order-level confirmation.

The online intake leads to provider review, with state eligibility and product choice resolved before prescribing.

The process is online, but patients need a saved checkout summary to resolve conflicting public terms.

Its weight-management catalog includes compounded, branded, microdose, and oral options.

Semaglutide and tirzepatide-based options are marketed, with product identity requiring precise verification.

Free delivery is advertised, although pharmacy and manufacturer routes vary by medication.

Shipping is advertised as included, but official delivery windows conflict.

Ongoing care is included, but split billing and fulfillment may require coordination.

Ongoing support is promoted without a consistently documented response or resolution standard.

Visible prices help comparison, while cancellation details still need confirmation before checkout.

The front-end flow is simple, while contradictory content makes an informed checkout harder than it should be.